Clinical Trial Update: To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory Allergies [Phase 2]

View source ↗

Summary

A Phase 2 trial investigated the safety, pharmacodynamics, and effect on allergic reactivity of the Toll-like Receptor 7 agonist GSK2245035 in subjects with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• GSK2245035 (GSK2245035)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Mild Asthma and Allergic Rhinitis | Phase 2 | Status: COMPLETED